IRB TESTING

Recruiting
All
Phase N/A

Brief description of study

See protocol section 2 See protocol section 2 See protocol section 2.

this is p tag.

header

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Gender: All

Inclusion Criteria:

  1. Pathologically confirmed invasive breast cancer
  2. Stage IIB-III invasive breast cancer (AJCC 8th edition)
  3. Patients planned for adjuvant chemotherapy and adjuvant radiotherapy
  4. Patients fit to receive adjuvant chemotherapy and radiotherapy
  5. Age > 18 years

Exclusion Criteria:

  1. Hypersensitivity to taxanes
  2. Patients receiving entire chemotherapy prior to surgery (neoadjuvant setting)
  3. Unable or unwilling for regular follow up
  4. Bilateral tumour needed RT to both sides
  5. Patients planned for RT to oligometastatic sites
  6. Unfavourable anatomical factors potentially leading to higher radiotherapy dose to heart and/or lungs (Exceeding the protocol specific mandatory dose constraints).
  7. Pregnant patient

Updated on 19 Mar 2026. Study ID: NCT7552977

Pre-Screener

Consent Compruebe si es elegible Ingrese los datos de contacto Select best time to contact

Are you above 18?

Preview complete

The prescreener preview is complete. You may now close the preview.

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.